BioVaria's technologies are presented as an all-day poster exhibition that enables industry representatives to gain a unique overview of undiscovered, licensable technologies and to discuss scientific details face-to-face with the inventors.
Additionally half of the technologies (marked with a * ) will also be presented as 10-min talks.
|
| Agrotechnology |
Abstract |
Presentation |
|
| Provendis |
P7 O. Becker, K. Fischer, J. Scharte, H. Schön, Z. Tjaden, A. von Schaewen
EukaResist |
 |
|
|
| Provendis |
P8 University of Münster
HypoPlant |
|
|
|
| Cardiovascular |
Abstract |
Presentation |
|
| Ascenion |
A2* Leibniz-Institiute for Molecular Pharmacology (FMP)
Inhibition of protein-protein interactions for the development of novel drug candidates to treat of cardiovascular diseases |
|
|
|
| DKFZ |
D5 DKFZ, Heidelberg
Use of ADAM 12 for diagnosis and therapy of preeclampsia |
|
|
|
| EMBLEM |
E3 University Clinic Heidelberg, Cardiology
Cardiac Troponin I sequence motifs inducing myocardial inflammation and fibrosis |
|
|
|
Drug Delivery |
Abstract |
Presentation |
|
| MI |
U6* University Hospital of Munich, Max Planck Society, Helmholtz Zentrum
Novel thermosensitive nanocarriers for drug targeting |
|
|
|
| Provendis |
P4 PROvendis GmbH
Nanocarrier |
|
|
|
| Drug Development |
Abstract |
Presentation |
|
| MI |
M1* Kinaxo Biotechnologies GmbH
Cellular Target Profiling™: Chasing drug actions and side effects |
|
|
|
| IPB |
I3 IP Bewertungs AG
New effective prodrug strategies |
|
|
|
| Fermentation |
Abstract |
Presentation |
|
| FIST |
U2 CNRS CERMAV
Economical production of bioactive complex sugars by microbial fermentation |
|
|
|
| Immune/Autoimmune |
Abstract |
Presentation |
|
Fraunhofer
VLS |
F3* Fraunhofer Institute for Cell Therapy and Immunology, Germany.
Antigen specific tolerance induction:
A new method to regulate the immune response specifically |
|
|
|
| DKFZ |
D2 University of Heidelberg, DKFZ, Heidelberg
Identifying tissue antigens that cause T-cell responds (UP-057) |
|
|
|
| Provendis |
P3 PROvendis GmbH
Atypical P-ANCA:
The main target antigen for use in diagnostic tests |
|
|
|
| Infection |
Abstract |
Presentation |
|
| Ascenion |
A3* Forschungszentrum Borstel
Synthetic Antimicrobial and LPS-Neutralizing Peptides (SALP) for prevention and treatment of sepsis |
|
|
|
| Bayerische Patentallianz |
B2* Institut für medizinische Mikrobiologie, Technische Universität München
Bacterial TIR domain mimics as autoimmune and anti-infective therapeutics |
|
|
|
| NGFN |
N1* TransMIT Gesellschaft für Technologietransfer mbH
Expression profiles for the prediction of septic states |
|
|
|
| VPM |
U4* Vakzine Projektmanagement GmbH
An improved vaccine for prophylaxis and treatment of tuberculosis (VPM 1002) |
|
|
|
| VPM |
U5* Vakzine Projektmanagement GmbH
A safe, well tolerated and efficacious vaccine against infection with HCMV (VPM2001)
|
|
|
|
| Ascenion |
A4 Helmholtz Zentrum München, Institute of Virology
A cell-based system for quantification of HIV infection and its application to broad scale HIV drug discovery |
|
|
|
| Ascenion |
A5 Zentrum für Neuropathologie und Prionforschung, LMU
MIRA CD8 T cells are a correlate of non-progressive HIV-1 infection |
|
|
|
| Bayerische Patentallianz |
B5 Fakultät für Chemie und Pharmazie, LMU München
β-Lactones as antibacterial agents |
|
|
|
| Medigate |
G1* University Medical Center Hamburg-Eppendorf
Antiadhesive strategies for bacterial infections |
|
|
|
| Metabolism |
Abstract |
Presentation |
|
| Provendis |
P1* PROvendis GmbH
FTO Knock-out |
|
|
|
| Bayerische Patentallianz |
B4 Julius-Maximilians-Universität Würzburg
Tripeptide that downregulates the activity of the sodium-D-glucose cotransporter SGTL1 |
|
|
|
| Neurological Disorders |
Abstract |
Presentation |
|
| Ascenion |
A1* Heinrich-Heine-Universität Düsseldorf
Peptides for the diagnosis and therapy of Alzheimer’s Disease |
|
|
|
| Bayerische Patentallianz |
B1* Zentrum für Neuropathologie und Prionforschung, LMU
Protein aggregation inhibitors as disease-modifying drugs for neurodegenerative diseases |
|
|
|
|
I2* IP Bewertungs AG
Use of Lornoxicam against Alzheimer´s Disease |
|
|
|
|
M2* Max-Planck-Institute of Neurobiology
Taxol induces axon regeneration |
|
|
|
|
M3 Affectis Pharmaceuticals AG
Use of Cimicoxib for the treatment of psychiatric disorders |
|
|
|
|
P5 PROvendis GmbH
Sigmagos |
|
|
|
Oncology |
Abstract |
Presentation |
|
DKFZ |
D1* DKFZ, Heidelberg
Redesigned bacterial killers for the treatment of breast cancer and melanoma (P–834) |
|
|
|
| DKFZ |
D6* DKFZ, Heidelberg
Platinum-Xanthates as Tumor Therapeutics |
|
|
|
Fraunhofer
VLS |
F2* Fraunhofer IZI
nONCOchip – a tool for the discovery of non-protein coding RNA biomarkers in oncology |
|
|
|
| Medigate |
G3* University Medical Center Hamburg-Eppendorf
Statins and astemizole block cell proliferation of small cell lung cancer cells in vitro |
|
|
|
| Multimmune |
U1* Multimmune GmbH
Targeted therapies against cancer based on the discovery of a novel tumor specific marker, „heat shock protein 70“ (Hsp70) |
|
|
|
| Bayerische Patentallianz |
B3 Institut für Org. Chemie, Julius-Maximilians-Universität Würzburg
Antitumoral and intiinfective compounds isolated from plants |
|
|
|
| DKFZ |
D3 Heidelberg University Hospital Medical School,
New early marker for pancreatic adenocarcinoma (UP-038) |
|
|
|
| DKFZ |
D4 DKFZ and Institute of Neuropathology, Heidelberg Universtiy Hospital
DDiagnostic and prognostic marker for glioma treatment (UP-074) |
|
|
|
Fraunhofer
VLS |
F1 Fraunhofer IZI
The STAT3 enhancer of micro RNA-21 – a novel target for therpeutic strategies in inflammatory diseases, autoimmune diseases and cancer |
|
|
|
| NGFN |
N3 German Cancer Research Center (DKFZ)
Gene expression signature for improved prognosis, diagnosis and therapy of prostate cancer |
|
|
|
| NGFN |
N4 German Cancer Research Center (DKFZ)
CITED4 as prognostic marker in oligodendroglial tumors |
|
|
|
Tools |
Abstract |
Presentation |
|
| IPB |
I1* IP Bewertungs AG
Terahertz biochip technology for high sensitivity label-free DNA sensors |
|
|
|
| EMBLEM |
E1* University Clinic Heidelberg, Immunology
miQPCR, improved quantification of microRNAs |
|
|
|
| EMBLEM |
E2* European Molecular Biology Laboratory, Heidelberg
Cell-based method for analysis of protein-protein interactions |
|
|
|
| FIST |
U3 Institut de Biologie Physico-Chimique, UMR
Amphipols as universal adapters to immobilise membrane proteins onto solid supports |
|
|
|
